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Figure 1. Transthoracic echocardiography: post-dive venous bubbles in right
heart chambers in a patient after catheter-based patent foramen ovale
closure.
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TCTAP A-117
Combined Transcatheter Aortic Valve Implantation (TAVI) and Stenting of the
Coronary Arteries in Patients with Severe Aortic Stenosis
David G. Iosseliani, Djamil Asadov, Igor Arabadzhyan, Vladislav Kriukov,
Elena Kovaleva, Anna Rogatova
City Center of Intervent. Cardioangiology, Moscow, Russian Federation
Background: To study the effectiveness and safety of combined PCI and aortic valve
implantation in patients at high surgical risk.
Methods: Combined correction of aortic stenosis and PCI were performed in 15
patients. The average age of patients was 76,3  3.9 years. Mean area of aortic valve
oriﬁce was 0.53  0.13 mm. Maximal transvalvular gradient was 99.7  20.2 mm Hg.
Four patients had single-vessel disease, the remaining patients had multivessel disease,
in two cases – with the lesion of the left main coronary artery. EuroScore>20%,
STS>10%, Syntax score ¼ 18,3  11,5.
Results: The ﬁrst stage of procedure was coronary stenting (2,2  0,75 stents per
patient), followed by TAVI. Mean duration of the procedure was 126.3  31.3 min.
The average volume of the contrast medium was 322.3  74.6 ml, the time of scopy–
36.6  9.6 min. Post-TAVI maximal transvalvular gradient was 15.4  5 mm Hg,
regurgitation – 1,2  0,5. There were no major intra- and perioperative complications.
Conclusion: Transcatheter aortic valve implantation combined with percutaneous
coronary interventions can be successfully used for the management of patients at
extremely high risk for open-heart surgery and is the only method of treatment for them.
TCTAP A-118
Improvement of LV Systolic and Diastolic Function 6-month After Successful
Transcatheter Aortic Valve Replacement (TAVR)
William K. F. Kong, Michael Liang, Kyu Kyu, K. K. Poh
The National University Heart Centre, Singapore, Singapore
Background: We prospectively evaluate the hemodynamic consequences of trans-
catheter aortic valve replacement (TAVR) with the Edward Sapien XT prosthesis
andits effect on left ventricular systolic and diastolic function.
Methods: From April 2011 to April 2013, symptomatic patients with severe aortic
stenosis (aortic valve area <1cm2) and underwent TAVR were included. Aortic valve
prosthesis was implanted via transfemoral, transapical and transaortical methods. All
procedures were guided by transeosphageal echocardiography. Clinical evaluation and
evaluation of LV systolic and diastolic function was performed at baseline and at six-
months after TAVR. Echocardiography included standard 2D and Doppler analysis of
global systolic and diastolic function as well as Tissue Doppler echocardiography.
Results: Thirty patients successfully underwent TAVR (66% were male). The mean
age was 79.
Conclusion: After successful TAVR for severe AS, LV systolic and diastolic function
was remarkably improved in most patients after 6 months. These changes will have
relevant clinical prognostic value.
TCTAP A-119
Catheter-based Patent Foramen Ovale Closure Eliminated Post-dive Arterial
Bubbles in Scuba Divers
Jakub Honek1, Martin Sramek1, Ludek Sefc2, Jaroslav Januska3, Jiri Fiedler1,
Martin Horvath1, Ales Tomek1, Stepan Novotny4, Tomas Honek1, Josef Veselka1
1Motol University Hospital, Prague, Czech Republic, 21st Faculty of Medicine,
Prague, Czech Republic, 3Trinec Podlesi Hospital, Trinec, Czech Republic, 4Kladno
Regional Hospital, Kladno, Czech Republic
Background: Patent foramen ovale (PFO) is a risk factor of decompression sickness
(DCS) in divers due to paradoxical embolization of bubbles. It has been suggested that
catheter-based PFO closure might prevent the arterialization of bubbles and reduce
the risk of DCS. However, there are currently no data conﬁrming its effect on post-
dive reduction of arterial gas emboli. The aim of this study was to test the effect of
catheter-based PFO closure on the occurrence of arterial bubbles after simulated dives.
Methods: A total of 183 consecutive divers were screened for PFO at our center.
Signiﬁcant PFO (grade 3 according to the International Consensus Criteria) was found
in total of 47 divers. Twenty divers (38.8+/-9.5 yrs, 80% males) with a history of
unprovoked DCS underwent catheter-based PFO closure (closure group). The other 27
divers (33.0+/-6.6 yrs, 81% males) were either asymptomatic or did not agree with
PFO closure, or their PFO closure had not been performed prior to study onset (PFO
group). All divers were examined after a simulated dive in a hyperbaric chamber:
thirty-four divers (19 PFO group, 15 closure group) performed a dive to 18 m for 80
min, and thirteen divers (8 PFO group, 5 closure group) performed a dive to 50 m for
20 min. Within 60 min after surfacing, presence of venous and arterial bubbles wasS34 JACC Vol 63/12/Suppl S j April 22–assessed. Venous bubbles were assessed by pulse wave Doppler in the right ven-
tricular outﬂow tract from the parasternal short axis view and their detection was
performed for 1 min. Arterial bubbles were detected by means of transcranial color-
coded sonography in the middle cerebral artery, bubbles were detected for 1 min
during native breathing and subsequently three times for 40 s after a Valsalva ma-
neuver. Tests were considered positive if one or more bubbles were detected.
Results: After the 18-m dive, venous bubbles were detected in 74% of divers in the
PFO group vs. 80% in the closure group (p¼1.0), and arterial bubbles were detected in
32% vs. 0%, respectively (p¼0.02). After the 50-m dive, venous bubbles were
detected in 88% vs. 100%, respectively (p¼1.0) and arterial bubbles were detected in
88% vs. 0%, respectively (p<0.01). The typical appearance of post-dive venous
bubbles in the right heart chambers and no arterial bubbles in the left heart chambers
in a diver with a PFO closure device is shown in Figure 1.Conclusion: The present study is the ﬁrst study to demonstrate the effect of catheter-
based PFO closure on the occurrence of post-dive arterial bubbles. In our study, no
difference was found in the occurrence of venous bubbles between the PFO and
closure groups. However, in the closure group no arterial bubbles were detected.
Therefore, we suggest that i) the presence of a PFO plays a key role in paradoxical
embolization of venous bubbles after scuba dives, ii) closure strategy should have a
role in the prevention of unprovoked DCS recurrence in divers.
Transradial Intervention
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TCTAP A-120
Intra-arterial Anti-spasm Regimens to Prevent Radial Artery Spasm During
Transradial Coronary Angiography
Babu Ezhumalai1, Santhosh Satheesh2, Balachander Jayaraman2
1Sri Venkateshwaraa Medical College Hospital and Research centre, Puducherry,
India, 2Jawaharlal Institute of Postgraduate Medical Education and Research,
Pondicherry, Puducherry, India
Background: The development of spasm of radial artery is a critical problem
encountered during transradial catheterization often leading to switching over to
transfemoral route. Various operators have used different kinds of regimens to prevent
the occurrence of radial artery spasm. This study was done to analyze the effect of
different anti-spasm regimens in preventing the development of radial artery spasm
during transradial coronary angiography.
Methods: Patients undergoing transradial coronary angiography were included in this
study. The radial sheath was inserted and ﬂushed with one of the following cocktail
regimens along with 50 units/kg of unfractionated heparin diluted in 10 ml of saline.
The various cocktails used were (i) Saline, (ii) Nitroglycerin 200mg, (iii) Nitroglycerin
200mg with Verapamil 2.5mg, (iv) Nitroglycerin 200mg with Diltiazem 5mg, (v)
Nicorandil 4mg. Hemodynamic parameters, ECG and other side effects were moni-
tored. Clinically, the severity of radial artery spasm was graded from 0 to 4 with Grade
0: No spasm and Grade 4: Painful spasm with severe resistance leading to entrapment
of catheter and/or sheath. Angiographically, the severity of radial artery spasm was
graded as mild, moderate and severe.
Results: A total of 1250 patients were included in this study. There were 250 patients in
each group.All the groupswere age and sexmatched. Compared to saline, the occurrence
of clinical and angiographic radial artery spasm was signiﬁcantly low with all cocktail25, 2014 j TCTAP Abstracts/POSTER/Structural Heart Disease, Other
19th CardioVascular Summit: TCTAP 2014regimens except for Nicorandil. There was not much hemodynamic alteration with
200mgNitroglycerin. The incidence of side effects ofNitroglycerin such as headachewas
also rare. In general, the combination ofNitroglycerin andCalciumChannel Blockerwas
better than either Nitroglycerin or Nicorandil in preventing the spasm of radial artery.
Verapamil 2.5mg used in combination with Nitroglycerin 200mg is better in preventing
radial artery spasm than combination ofDiltiazem 5mg andNitroglycerin 200mg. Rashes
and vasovagal phenomenon was seen to occur more commonly with Diltiazem.
Conclusion: The occurrence of radial artery spasm during transradial coronary
angiography is prevented by intraarterial injection of Nitroglycerin with or without
calcium channel blocker. The best regimen to prevent spasm of radial artery in an ideal
patient is the combination of 200mg of Nitroglycerin with 2.5mg of Verapamil.
Nicorandil was less effective in preventing radial artery spasm.
TCTAP A-121
Transradial Versus Transfemoral Intervention in ST-segment Elevation
Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary
Intervention with Drug-eluting Stents
Seung-Woon Rha1, Byoung Geol Choi1, Dong Joo Oh1, Myung Ho Jeong2,
Sang Sik Jung3, Moo Hyun Kim4, Hyoung-Mo Yang5, Junghan Yoon6,
Keum Soo Park7, Kyoo Rok Han8, Byung Ryul Cho9, Kwang Soo Cha10,
Byung Ok Kim11, Min Soo Hyun12, Won Yong Shin13, Hyunmin Choe14,
Jang-Whan Bae15, Hee Yeol Kim16
1Korean University Guro Hospital, Seoul, Korea (Republic of), 2Chonnam National
university, GangNeung, Korea (Republic of), 3Ulsan University GangNeung Asan
Hospital, GangNeung, Korea (Republic of), 4Dong-A University Medical Center,
Pusan, Korea (Republic of), 5Ajou University Hospital, Suwon, Korea (Republic of),
6Yonsei University Wonju Hospital, Wonju, Korea (Republic of), 7Inha University
Hospital, Incheon, Korea (Republic of), 8Hallym University Kangdong Sacred Heart
Hospital, Seoul, Korea (Republic of), 9Kangwon National University Hospital,
Chuncheon, Korea (Republic of), 10Pusan National University Hospital, Busan, Korea
(Republic of), 11Inje University Sanggye Paik Hospital, Seoul, Korea (Republic of),
12SoonChunHyang University Seoul Hospital, Seoul, Korea (Republic of),
13Soonchunhyang University Cheonan Hospital, Cheonan, Korea (Republic of), 14Inje
University llsan Paik Hospital, llsan, Korea (Republic of), 15Chungbuk National
University Hospital, Cheongju, Korea (Republic of), 16The Catholic University of
Kores Bucheon St. Mary’s Hospital, Bucheon, Korea (Republic of)
Background: Transradial intervention (TRI) is drastically increasing in every inter-
vention society around the world because of lower incidence of major bleeding and
vascular complications compared with trans-femoral intervention (TFI). However,
there have been limited data regarding clinical outcomes of TRI versus TFI in ST
elevation myocardial infarction (STEMI) patients (pts) in Asian population.
Methods: A total of 689 consecutive STEMI pts from nine major hospitals were
enrolled from Jan to Dec 2009. Cumulative major clinical outcomes up to 12 months
were compared between TRI (n¼220, 31.9%) and TFI group (n¼469, 28.1%).
Results: Baseline characteristics showed that TRI group had more smokers and a
higher incidence of hypertension, diabetes mellitus and previous cerebrovascular ac-
cidents whereas TFI group had a higher incidence of multi-vessel disease, left
circumﬂex lesion, type B2 or C lesion and chronic total occlusion. TRI group had a
lower incidence of major and minor hemorrhage during admission. Clinical outcomes
up to 12 months showed that the incidence of recurrent myocardial infarction, target
lesion revascularization (TLR) and target vessel revascularization (TVR) were lower
in the TRI group. Propensity score matched analysis showed that TRI was an inde-
pendent predictor of reducing TVR (OR: 0.08 95% CI: 0.01-0.67, p Value¼0.019),
MACE (OR: 0.37, 95% CI: 0.15-0.86, p Value¼0.022), and MACCE (OR: 0.33, 95%
CI: 0.14-0.76, p Value¼0.010) at 12 months.
Conclusion: In our study, TRI in STEMI pts undergoing primary PCI with DES was
associated with lower 12-months TVR, MACE and MACCE. We suggest that TRI
may play an important role in improving mid-term major clinical outcomes of STEMI
pts undergoing PCI with DESs.JACC Vol 63/12/Suppl S j April 22–25, 2014 j TCTAP Abstracts/POST
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The Use of Sheathless Eaucath to Overcome Radial Artery Spasm and
Perforation
Michael Liang1, Sonia Burgess2, Andrew Aitken1, Phil Matsis1, Mark Simmonds1,
Anil Ranchord1, Scott Harding1
1Wellington Hospital, Wellington, New Zealand, 2Liverpool Hospital, Sydney,
Australia
Background: Transradial access (TRA) for percutaneous coronary intervention and
diagnostic coronary angiography has become an emerging trend in the routine practice
in most catheterization laboratory as it reduces the incidence of major access site
complications such as bleeding and haematoma. Radial artery spasm and perforation
are the main reasons for converting a procedure to femoral access. We prospectively
investigate the use of Sheathless EauCath (Asahi Intecc, Aichi, Japan) in cases of
radial artery spasm and perforation.
Methods: From Jan 2011 till Oct 2013, all patients with angiographically documented
radial artery spasm with or without perforation and failure of conventional 5 or 6 Fr
diagnostic or guiding catheters to cross the artery despite of repeated intra-arterial
nitroglycerin and/or verapamil were elected to attempt for Sheathless EauCath. The
procedural success, angiography of the forearm post procedure and access site out-
comes were evaluated.
Results: 36 patients, amean age of 619 yrswith 64%male, had signiﬁcant radial artery
spasm (n¼25, 69%) or perforation+spasm (n¼11, 31%) fulﬁlled the criteria for the use
of Sheathless EauCath. Procedural indications are stable angina in 18%, unstable angina
in 3%, non-ST elevation myocardial infarction (NSTEMI) in 54%, ST-elevation
myocardial infarction (STEMI) in 15% and 10% for other diagnostic procedures. 6.5 Fr
Sheathless EauCathwas used in 34 patients (94%) and 7.5 Frwas used in the remaining 2
patients (6%). The Sheathless EauCath was able to overcome the spasm with or without
perforation in all caseswith all patients achieved a successful procedural outcome.Of the
11 patients who had perforation of the radial artery, 10 patients (91%) had post-proce-
dural angiography showed no extravasation of contrast. The remaining one patient who
had trivial residual contrast extravasation outside the radial artery was successfully
managed with pressure dressing without signiﬁcant complications. There was no case of
haematoma or access site related bleeding issues.
Conclusion: The Sheathless EauCath can be used safely to overcome the radial artery
spasm and perforation during transradial coronary intervention or diagnostic procedures.
TCTAP A-123
Feasibility of Transradial Coronary Intervention in Patients with Cardiac Arrest
Caused by Acute Coronary Syndrome
Yukio Mizuguchi, Akihiko Takahashi, Takeshi Yamada, Norimasa Taniguchi,
Shunsuke Nakajima, Tetsuya Hata
Sakurakai Takahashi Hospital, Kobe, Japan
Background: The latest EuropeanSociety ofCardiologyguidelines for themanagement
of acute myocardial infarction (AMI) in patients with ST-segment elevation recommend
transradial coronary intervention (TRI) to reduce the risk of vascular complications. We
evaluated the feasibility of TRI in patients with AMI complicated by cardiac arrest.
Methods: We retrospectively evaluated 20 consecutive patients with AMI who
required an extracorporeal membrane oxygenator (ECMO) because of cardiopulmo-
nary arrest resistant to conventional cardiopulmonary resuscitation. Percutaneous
access sites and evaluation criteria, including onset-to-ECMO time, door-to-balloon
time, and 30-day survival, were investigated.
Results: TRI was performed in 13 patients, whereas the other 7 patients underwent
transfemoral coronary intervention (TFI). No signiﬁcant differences in onset-to-
admission time (mean  SD: 26.8  14.6 vs. 17.0  13.3 min), onset-to-ECMO time
(41.8  18.8 vs. 39.0  16.6 min), and door-to-balloon time (61.4  19.1 vs. 79.3 ER/Transradial Intervention S35
